Technical procedures which have been developed for quantitative measurements of the rate of excretion of the porphyrins have advanced the knowledge of the fundamental nature of certain anemic states. By such studies the disorders of hematopoiesis may be divided into two major groups on a pathological-physiological basis. In one group the metabolism of the pigments is quantitatively increased but is normal in type. Pernicious anemia, congenital hemolytic jaundice, and the anemia caused by phenylhydrazine are all of this variety (1, 2, 3, 4, 5) . In a second group, however, a qualitative as well as a quantitative deviation from the normal metabolism of pigments exists. The anemia of lead (6, 7, 8) and salvarsan poisoning (9) , and of certain hepatic cirrhoses, notably hemachromatosis, are of this type (1, 10) .
Recent advances in the treatment of pernicious anemia and the anemias of a deficiency of iron and copper have made prominent a group of blood dyscrasias which does not respond to the administration of liver extract or of iron. Cases of this type which are apparently primary are termed aplastic, aregenerative or achrestic anemia, and compose a group of general as well as of physiological interest.
The cause of primary aplastic anemia is obscure in most instances, although certain cases are encountered in which exposure to benzol, gold, or arsphenamine seems to have been etiological.
Histological study of the hematopoietic bone marrow in these toxic cases shows no consistent difference from the lesions in patients clinically similar but who give no history of exposure to potentially toxic compounds.
Aplastic anemia is, then, therapeutically unlike pernicious anemia or the microcytic anemias, and certain cases seem to be toxic in origin. Studies of the metabolism of the pigments in cases of aplastic anemia should establish conclusively whether the underlying physiological disturbance is like that of the deficiency or of the toxic group.
In the course of a study of refractory anemia, detailed observations of the metabolism of pigments have been made in six patients. Studies of one such case have been reported by Brugsch (11) . The cases were selected to represent as closely as possible the different subgroups into which aplastic anemia may be divided (12) .
To render the rationale of this study and the validity of the results intelligible, the brief review by Dobriner and Rhoads of the chemistry of the porphyrins should be consulted (13) .
METHODS
The chemical and physical procedures which have been employed for the qualitative and the quantitative determinations of the excretion of porphyrins are those which have been reported previously (1, 2) . The total outputs of urine and stools have been collected with toluol as a preservative for periods of three days and aliquot fractions analyzed. Determinations of the content of urobilin have been made by the method of Watson (14) . The excretion of porphyrin is expressed in micrograms for the daily average of each 3-day period, the excretion of urobilin in milligrams. In the figures, the average levels of daily excretion are presented for the various periods of treatment. The second period of observation was of 54 days. During the first 9-day control period the total output of coproporphyrin averaged 310 micrograms per day, of which 87 were in the urine. During this time the patient was transfused, and the excretion of coproporphyrin increased. Because of this fact a second control period of 12 days was used, during which the coproporphyrin averaged 243 micrograms per day, of which 65 were in the urine. The latter value is appreciably lower than normal. During the remainder of the study the patient was transfused several times, treated with vitamin C and with liver extract, without significant change in the excretion of coproporphyrin. The urobilin averaged 133 mgm. per day for a 3-day period.
The excreted porphyrin was identified by the melting point as coproporphyrin I (222°C.) and small amounts of coproporphyrin III (1430 C.).
Case 3 (F. Y.) ( Figure 3 Case 4 (G. M.) (Figure 4) . A 34-year old ship steward was admitted with anemia of one year's duration. He had had malaria in 1917 and 9 years prior to admission he developed psoriasis, which was treated by x-ray therapy from 1930 to 1935. One year after the last treatment he developed fever and weakness and was admitted to another hospital with a severe anemia which was refractory to treatment. Physical examination on admission to this institution was not remarkable. The erythrocytes numbered 1,640,000, the hemoglobin was 30 per cent, the mean corpuscular volume 84, the platelets 136,000, and the reticulocytes 5 per cent. Free hydrochloric acid was present in the gastric juice, tests of liver function were normal, the icteric index was 6. The fragility of the erythrocytes was normal. The patient had received eleven transfusions.
A biopsy of the sternal bone marrow revealed a normal degree of cellularity, and active hematopoiesis was apparently proceeding. No marked interference with maturation of hematopoietic cells was apparent.
Quantitative determinations of the excretion of coproporphyrin were made for a period of 75 days. Besides coproporphyrin relatively large amounts of protoporphyrin and small amounts of deuteroporphyrin were present in the feces.
During a 12-day control period the total excretion of coproporphyrin averaged 492 micrograms, and of this 212 were in the urine, both definitely elevated values. The urobilin excretion averaged 380 mgm. per day, a high level. During the subsequent 12-day period liver extract was given intramuscularly without significant effect on the excretion of porphyrin. For the next 15 days the patient received 1 gram of ascorbic acid by mouth daily. The excretion of coproporphyrin in the urine decreased to an average of 126 micrograms per day, and the total output of coproporphyrin to 395 micrograms. The output of coproporphyrin in the feces remained constant, and the observed decrease in the total output was consequent to the decreased amount in the urine. Except for one high value, the levels during this period were lower than in the control and in the previous liver period. In a subsequent 9-day period concentrated liver extract and 1 gram of vitamin C were administered daily. The average output for this period decreased to 275 micrograms, of which 93 were in the urine, levels which are distinctly lower than normal. This period was followed by a 15-day period during which 1 gram of vitamin C alone was administered daily. The total output of coproporphyrin rose to average 343 micrograms per day.
The rise was principally in the porphyrin of the feces, the urinary coproporphyrin averaging 68 micrograms. The final 12 days of observation were utilized as an untreated control period and the total excretion of coproporphyrin increased again to an average of 455 micrograms per day, approaching the values of the first control period.
During the period of study the patient was transfused 4 times without significant change in the rate of excretion of coproporphyrin.
The levels of the excretion of urobilin following liver extract and vitamin C decreased, and following the termination of therapy, increased to the level before treatment.
The excreted coproporphyrin was proved to be a mixture of coproporphyrin I (2330 C.) and III (138/165°C
.) by melting point determinations.
Case 5 (W. G.) ( Figure 5 The erythrocytes numbered 2,010,000, and the hemoglobin 40 per cent. The leukocytes were 2,400, the platelets 250,000, and the reticulocytes 0.8 per cent. The fragility of the erythrocytes was normal. In spite of blood transfusions the patient became rapidly worse, the erythrocytes decreasing to 1,420,000 and the hemoglobin to 27 per cent. The leukocytes fell to 1,300, and no reticulocytes were demonstrable. are approximately three times normal. The urobilin averaged 273 per day for a period of 3 days.
The excreted porphyrin was proved to be a mixture of coproporphyrin I (2320 C.) and III (1400 C.) by determinations of the melting points.
Case 6 (A. C.) (Figgre 6) . A single male photographic worker of 22 with anemia of 2 months' duration. In his work this patient was exposed to hydroquinone and other potentially toxic agents. Onset with epistaxis, weakness, purpura, and pallor. Six Biopsy of the sternal bone marrow showed practically complete aplasia of the hematopoietic tissue.
During a control period of 21 days the patient excreted daily an average of 694 micrograms of coproporThe output of coproporphyrin averaged 978 micrograms phyrin, of which 201 were contained in the urine. In the per day, and of this 550 were in the urine. These levels subsequent 18 days he received 2 grams of crystalline vitamin C daily by mouth, but no effect on the excretion of porphyrin was detectable since the daily average was 627 micrograms, of which 208 were in the urine. It is striking that in the periods of 3 days each, which followed 3 transfusions of blood with febrile reaction, there was a distinct increase in the output of coproporphyrin. During the next 12 days S cc. of concentrated liver extract (Lederle and Co.) was administered each day intramuscularly. This was accompanied by a sharp decrease in the excretion of coproporphyrin to a daily average of 320 micrograms, of which 141 were in the urine. In 5 subsequent control periods of 12 days each with vitamin C the excretion of coproporphyrin was increased but was still definitely less than in the original control period. During this time the increased output of coproporphyrin following transfusion is once more apparent. An increased amount of protoporphyrin was present in the stools and also a small amount of deuteroporphyrin.
The excreted coproporphyrin was identified as a mixture of coproporphyrin I (2320 C.) and coproporphyrin III (142/165°C.) by determination of the melting point.
DISCUSSION
The quantitative and qualitative excretions of coproporphyrin are summarized in Table I , together with the levels of the excretion of urobilin, and the hematological and bone marrow findings.
Four cases (Numbers 2, 4, 5, and 6) showed a mixed excretion of Type I and Type III coproporphyrin. In 2 cases (Numbers 1 and 3) , although coproporphyrin III was not definitely identified, its presence was indicated. Since only inaccurate quantitative methods for the separation of the isomers are available, the quantitative relations between coproporphyrin I and III cannot be determined. Approximately estimated, about one-fifth of the excreted coproporphyrin in Cases 4, 5, and 6 was coproporphyrin III. In Cases 2 and 3 probably less than one-tenth of the total excretion was coproporphyrin III.
The simultaneous excretion of Types I and III coproporphyrin in aplastic anemia indicates that the metabolism of pigment in that condition is different from any which has been observed in normal individuals, in hemolytic jaundice, or in pernicious anemia. Furthermore, the disturbance in aplastic anemia differs from that observed in congenital porphyria where mass excretion of Type I coproporphyrin reverses the normal ratio between the construction rate of Type I and Type III porphyrins. The mixed excretion does, however, bear some similarity to that which has been reported in certain diseases of the liver, such as pigment cirrhosis and melanosarcoma, in lead and salvarsan intoxication, and in the conditions classified as acute and chronic porphyria.
The excretion of Type III coproporphyrin indicates a faulty metabolism of pigment, and results from either faulty construction or destruction of the respiratory pigments in any stage of their genesis or breakdown. Whether either or both of these theoretical possibilities is responsible has not yet been determined.
Of the six cases studied, three showed a hyperplastic and three a hypoplastic bone marrow. The three patients with hyperplastic marrow showed an increased excretion of coproporphyrin. Of the cases with hypoplastic marrow two showed a decreased excretion, and one a marked increase. No explanation of the last case is at hand. In only one case was an apparently definite effect of vitamin C on the excretion of porphyrin noted.
In this instance the decreased excretion of porphyrin was due to a decrease in the coproporphyrin of the urine alone. In Cases 4 and 6 the excretion of coproporphyrin decreased following liver therapy, and was further decreased in Case 4 when liver and vitamin C were used together, although vitamin C alone produced little or no effect. The mechanism of these possible changes is not known. However, unpublished studies of congenital porphyria have shown that both liver (15) 
